OBSTETRICS: ETHICS, MEDICOLEGAL ISSUES, AND PUBLIC POLICYProfitability of Large Pharmaceutical Companies Compared With Other Large Public CompaniesLedley, Fred D.; McCoy, Sarah Shonka; Vaughan, Gregory; Cleary, Ekaterina GalkinaAuthor Information Department of Natural & Applied Sciences, Center for Integration of Science and Industry (F.D.L.), and Departments of Management (F.D.L.) and Accountancy (S.S.M.), Bentley University, Waltham, MA; Department of Accounting, University of New Mexico, Albuquerque, NM (S.S.M.); and Center for Integration of Science and Industry (E.G.C.) and Department of Mathematical Sciences (G.V., E.G.C.), Bentley University, Waltham, MA Obstetrical & Gynecological Survey: August 2020 - Volume 75 - Issue 8 - p 452-454 doi: 10.1097/01.ogx.0000695056.94192.53 Buy Metrics Abstract (Abstracted from JAMA 2020;323(9):834–843) Virtually all of the US Food and Drug Administration–approved medications in the United States were developed by for-profit companies, thus demonstrating the importance of these corporations in providing medicine to the public. Understanding both drug costs and company profits is vital to creating evidence-based policies that balance the cost of medicine with the industry's ability to innovate. Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.